Amy Trombly - Jan 2, 2025 Form 4 Insider Report for Sonoma Pharmaceuticals, Inc. (SNOA)

Role
Chief Executive Officer
Signature
/s/ Amy Trombly
Stock symbol
SNOA
Transactions as of
Jan 2, 2025
Transactions value $
$0
Form type
4
Date filed
1/3/2025, 05:02 PM
Previous filing
Jun 21, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNOA Restricted Stock Units Award $0 +10K +115.14% $0.00 18.7K Jan 2, 2025 Common Stock 10K $0.00 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock.
F2 The RSUs vest one-third each on July 2, 2025, July 2, 2026 and January 2, 2027, or upon change of control.
F3 The RSUs were awarded and granted to Ms. Trombly for services performed as part of the Company's annual equity grant.